Aspira Financial Statements From 2010 to 2022

AWH
 Stock
  

USD 0.94  0.01  1.05%   

Aspira Womans financial statements provide useful quarterly and yearly information to potential Aspira Womans Health investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Aspira Womans financial statements helps investors assess Aspira Womans' valuation, profitability, and current liquidity needs.
We have found ninety-nine available fundamental signals for Aspira Womans Health, which can be analyzed and compared to other ratios and to its rivals. Please verify all of Aspira Womans Health prevailing fundamental drivers against the trend between 2010 and 2022 to make sure the company can sustain itself down the road.
Aspira Womans Average Equity is most likely to increase significantly in the upcoming years. The last year's value of Average Equity was reported at 41.96 Million. The current Invested Capital Average is estimated to increase to about 598.3 K, while Net Income Per Employee is projected to decrease to (316.3 K).
  
Check Aspira Womans financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aspira main balance sheet or income statement drivers, such as Direct Expenses of 4 M, Cost of Revenue of 3.2 M or Gross Profit of 3.3 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.0925, PPandE Turnover of 14.04 or Receivables Turnover of 10.21. Aspira financial statements analysis is a perfect complement when working with Aspira Womans Valuation or Volatility modules. It can also supplement Aspira Womans' financial leverage analysis and stock options assessment as well as various Aspira Womans Technical models . Please continue to the analysis of Aspira Womans Correlation against competitors.

Aspira Womans Revenues

5.49 Million

Aspira Womans Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets32.6 M41.1 M20.4 M
Increasing
Stable
Cash and Equivalents29.6 M37.4 M18.4 M
Increasing
Stable
Deferred Revenue451.7 K440.1 K775 K
Decreasing
Slightly volatile
Property Plant and Equipment Net882.4 K810 K751 K
Increasing
Slightly volatile
Inventory141.5 K174 K90.7 K
Increasing
Stable
Trade and Non Trade Receivables1.1 MM473.2 K
Increasing
Slightly volatile
Trade and Non Trade Payables1.3 M1.5 MM
Increasing
Stable
Total Liabilities9.3 M10.9 M6.9 M
Decreasing
Very volatile
Shareholders Equity32.6 M30.2 M14.2 M
Increasing
Slightly volatile
Current Assets43.2 M40 M20.5 M
Increasing
Stable
Assets Non CurrentM1.1 M794.7 K
Increasing
Slightly volatile
Current Liabilities8.5 M7.8 M5.6 M
Decreasing
Stable
Liabilities Non Current2.5 M3.1 M1.4 M
Increasing
Slightly volatile
Total Debt3.7 M4.1 MM
Decreasing
Stable
Debt Current1.1 MM1.7 M
Decreasing
Slightly volatile
Debt Non Current2.8 M3.1 M1.9 M
Increasing
Slightly volatile
Shareholders Equity USD32.6 M30.2 M14.2 M
Increasing
Slightly volatile
Cash and Equivalents USD29.6 M37.4 M18.4 M
Increasing
Stable
Total Debt USD3.7 M4.1 MM
Decreasing
Stable
Accounts Payable1.2 M1.5 MM
Increasing
Slightly volatile
Receivables1.1 MM476.1 K
Increasing
Slightly volatile
Inventories187.7 K174 K94.3 K
Increasing
Stable

Aspira Womans Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues5.5 M6.8 M3.3 M
Increasing
Slightly volatile
Cost of Revenue3.2 M3.8 MM
Increasing
Slightly volatile
Selling General and Administrative Expense24.3 M30.3 M15.2 M
Increasing
Slightly volatile
Research and Development Expense5.7 M5.3 M3.2 M
Decreasing
Stable
Operating Expenses28.7 M35.7 M18.3 M
Increasing
Slightly volatile
Interest Expense62.3 K48 K84.3 K
Decreasing
Slightly volatile
Preferred Dividends Income Statement Impact842.8 K847.8 K927.1 K
Decreasing
Slightly volatile
Weighted Average Shares90.7 M111.2 M55.1 M
Increasing
Slightly volatile
Weighted Average Shares Diluted90.7 M111.2 M55.1 M
Increasing
Slightly volatile
Revenues USD5.5 M6.8 M3.3 M
Increasing
Slightly volatile
Gross Profit3.3 M3.1 M1.4 M
Increasing
Stable
Direct ExpensesM3.8 M2.1 M
Increasing
Slightly volatile

Aspira Womans Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow Business Acquisitions and Disposals1.6 M1.6 M1.8 M
Decreasing
Slightly volatile
Net Cash Flow from Financing52.2 M48.4 M18.5 M
Increasing
Slightly volatile
Issuance Repayment of Debt Securities (213.6 K)(198 K)(1.2 M)
Increasing
Slightly volatile
Issuance Purchase of Equity Shares52.8 M49 M19.2 M
Increasing
Slightly volatile
Net Cash Flow from Investing(198.5 K)(184 K)(188.9 K)
Decreasing
Stable
Effect of Exchange Rate Changes on Cash 2.7 K2.7 KK
Decreasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents22.4 M20.8 M2.8 M
Increasing
Slightly volatile
Share Based Compensation2.8 M3.5 M1.8 M
Increasing
Very volatile
Depreciation Amortization and Accretion379.2 K339 K328.5 K
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Return on Invested Capital(58.51)(57.014)(9.0675)
Decreasing
Very volatile
Gross Margin0.40.450.4295
Decreasing
Slightly volatile
Asset Turnover0.180.1310.1821
Increasing
Slightly volatile
Enterprise Value over EBITDA(5.41)(5.011)(6.2872)
Decreasing
Slightly volatile
Sales per Share0.06360.0610.0785
Decreasing
Slightly volatile
Price to Sales Ratio33.9128.89630.6111
Increasing
Slightly volatile
Price to Book Value6.756.57812.5623
Increasing
Slightly volatile
Debt to Equity Ratio0.480.3610.7134
Decreasing
Stable
Current Ratio4.365.1033.8549
Increasing
Stable
Book Value per Share0.30.2710.3806
Decreasing
Slightly volatile
Tangible Assets Book Value per Share0.420.3690.6147
Decreasing
Slightly volatile
Total Assets Per Share0.550.36630.6048
Decreasing
Slightly volatile
Receivables Turnover10.217.200811.4306
Decreasing
Slightly volatile
Inventory Turnover41.1336.764740.8726
Increasing
Slightly volatile
PPandE Turnover14.0413.01247.5357
Increasing
Stable
Cash and Equivalents Turnover0.230.25320.2387
Increasing
Slightly volatile
Accounts Payable Turnover5.555.14113.3703
Increasing
Slightly volatile
Accrued Expenses Turnover1.41.52791.4297
Increasing
Slightly volatile
Long Term Debt to Equity0.09250.09010.2475
Decreasing
Stable
Quick Ratio4.23.8972.2373
Increasing
Stable
Net Current Assets as percentage of Total Assets68.5778.300365.2572
Increasing
Stable
Revenue to Assets0.170.16580.1987
Increasing
Slightly volatile

Aspira Womans Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Capitalization179.3 M198.5 M124.5 M
Increasing
Slightly volatile
Enterprise Value148 M156.7 M107 M
Increasing
Slightly volatile
Invested Capital(90.6 K)(84 K)(669 K)
Increasing
Slightly volatile
Average Equity45.3 M42 M16.3 M
Increasing
Slightly volatile
Average Assets55.9 M51.8 M24 M
Increasing
Stable
Invested Capital Average598.3 K554.5 K(202 K)
Increasing
Slightly volatile
Tangible Asset Value32.6 M41.1 M20.4 M
Increasing
Stable
Working Capital34.7 M32.2 M14.9 M
Increasing
Slightly volatile
Revenue Per Employee75.9 K63.1 K74 K
Decreasing
Very volatile

Aspira Fundamental Market Drivers

Short Percent Of Float2.65%
Forward Price Earnings-2.86
Shares Short Prior Month5.37M
Average Daily Volume Last 10 Day276.43k
Average Daily Volume In Three Month899.63k
Date Short Interest15th of July 2022
Fifty Day Average0.7612
Two Hundred Day Average1.2477

Aspira Upcoming Events

Upcoming Quarterly Report24th of March 2022
Next Financial Report12th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End24th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

About Aspira Womans Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Aspira Womans income statement, its balance sheet, and the statement of cash flows. Aspira Womans investors use historical funamental indicators, such as Aspira Womans's revenue or net income, to determine how well the company is positioned to perform in the future. Although Aspira Womans investors may use each financial statement separately, they are all related. The changes in Aspira Womans's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Aspira Womans's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Aspira Womans Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Aspira Womans. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Deferred Revenue440.1 K451.7 K
Cost of Revenue3.8 M3.2 M
Revenues6.8 M5.5 M
Revenue to Assets 0.17  0.17 
Revenue Per Employee63.1 K75.9 K
Aspira Womens Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. Aspira Womens Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas. Aspira Womans operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 106 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Aspira Womans without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Balance Of Power Now

   

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Module

Pair Trading with Aspira Womans

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aspira Womans position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspira Womans will appreciate offsetting losses from the drop in the long position's value.

Moving against Aspira Womans

0.72AGTCApplied Genetic Tech Fiscal Year End 22nd of September 2022 PairCorr
0.6GTHGenetron Holdings Earnings Call  This WeekPairCorr
The ability to find closely correlated positions to Aspira Womans could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aspira Womans when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aspira Womans - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aspira Womans Health to buy it.
The correlation of Aspira Womans is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aspira Womans moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aspira Womans Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aspira Womans can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to the analysis of Aspira Womans Correlation against competitors. Note that the Aspira Womans Health information on this page should be used as a complementary analysis to other Aspira Womans' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Aspira Stock analysis

When running Aspira Womans Health price analysis, check to measure Aspira Womans' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspira Womans is operating at the current time. Most of Aspira Womans' value examination focuses on studying past and present price action to predict the probability of Aspira Womans' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aspira Womans' price. Additionally, you may evaluate how the addition of Aspira Womans to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Is Aspira Womans' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womans. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womans listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
106.3 M
Quarterly Revenue Growth YOY
0.15
Return On Assets
-0.57
Return On Equity
-1.19
The market value of Aspira Womans Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womans' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womans' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womans' market value can be influenced by many factors that don't directly affect Aspira Womans' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womans' value and its price as these two are different measures arrived at by different means. Investors typically determine Aspira Womans value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womans' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.